Want to track RV7 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 73 days
 RV7 Halozyme Therapeutics Inc. 17 Feb 2026 (In 2 months) | | 1.9 Cons. EPS | - EPS |
| RV7 Halozyme Therapeutics Inc. 3 Nov 2025 | | 1.59 Cons. EPS | - EPS |
| RV7 Halozyme Therapeutics Inc. 29 Oct 2025 | | - Cons. EPS | - EPS |
| RV7 Halozyme Therapeutics Inc. 4 Aug 2025 | | - Cons. EPS | - EPS |
| RV7 Halozyme Therapeutics Inc. 6 May 2025 | | - Cons. EPS | - EPS |
RV7 Earnings Reports FAQ
What is the earnings per share (EPS) for RV7?
The current EPS is 2.74.
What is the company's earnings growth rate?
Halozyme Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-17, based on the RV7's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Halozyme Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RV7 at this time, as Halozyme Therapeutics Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
